Transesophageal Echocardiography in Congenital Heart Disease – A Vital Component in Imaging

Congenital heart disease (CHD) is the most common form of birth defect worldwide. In the United States alone, over 40,000 children are born annually with CHD and the number of children and adults living with CHD is estimated at two to three million. Transthoracic echocardiography (TTE) has always been an essential non-invasive diagnostic tool for pediatric cardiologists, but recent advances in transesophageal echocardiography (TEE) technology have led to its increasing importance in the care of both children and adults with CHD. A new document, Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination in Children and All Patients with Congenital Heart Disease: Recommendations from the American Society of Echocardiography, provides a comprehensive review of the optimal application of TEE for patients with CHD. Read more here.

ASE Headquarters – COVID-19 Update

Beginning March 26, 2020, the county where the ASE Headquarters is located is under a government order to “Stay at Home” due to the spread of the coronavirus. These “Stay at Home” recommendations continue to be in effect and depend on the infection rates in the County/State. ASE will keep all but essential personnel telecommuting until a time when it is judged safe to return to work. We are not suspending or closing operations; our employees will remain working and providing excellent customer service to our members and the cardiovascular ultrasound community. However, ASE will slightly modify its official open hours to 9 AM – 4 PM Eastern TimeMonday-Friday. Should you need to get in touch with a staff person, call our main office at 919-861-5574 and a phone list by department will be available. A staff directory is also available here. All general questions can also be sent through ASE@ASEcho.org. Thank you and our best wishes for your continued safety.